Goals of work Severe oral mucositis induced by allogeneic hematopoietic cell transplantation (HCT) is associated with intolerable pain and risk of systemic bacteremia infection. Differences between conventional HCT and reducedintensity regimens for allogeneic HCT (RIST) may influence the occurrence and severity of oral mucositis. Here, we evaluated oral mucositis in patients undergoing RIST and compared the results with those in conventional allogeneic HCT patients to facilitate predictive measures for mucositis. Patients and methods A total of 127 consecutive patients undergoing HCT (conventional, 63; RIST, 64) were included in this study. Severity of oral mucositis during HCT period was evaluated daily. Differences in severity of mucositis among HCT types were analyzed. Use of morphine to control pain due to oral mucositis was evaluated in each HCT method. Main results The severity of oral mucositis was reduced in patients undergoing RIST. Worsening of oral mucositis was delayed in patients receiving RIST. Use of morphine to control pain due to oral mucositis was significantly decreased in patients undergoing RIST compared with those receiving conventional allogeneic HCT. Conclusions The severity of oral mucositis was reduced and the peak day of oral mucositis was delayed in RIST patients compared with those receiving conventional HCT.
Introduction
Oral mucositis is one of the most common symptomatic complications associated with chemotherapy, especially hematopoietic stem cell transplantation (HCT) [5, 6] . Severe mucositis is associated with not only intolerable pain but also the possible risk of systemic bacteremia infection. Oral mucositis is a significant cause of suffering and morbidity in patients receiving myeloablative chemo-therapy [1] . Effective interventions to alleviate this complication without promoting infection are needed [1] .
To provide measures for effectively alleviating oral mucositis, it is very important to clarify the clinical time course of oral mucositis during the HCT period. The clinical course of conventional allogeneic HCT is relatively predictable. The severity of clinically evident mucosal damage generally increases and peaks between 6 and 12 days post-HCT with resolution of uncomplicated mucositis occurring over the subsequent 7 to 10 days [2, 8] .
Reduced-intensity chemotherapy regimens for allogeneic HCT (RIST) have been developed over the past decade to extend HCT therapy to older patients or those with comorbidities. The conditioning regimens typically include a purine analog, such as fludarabine, an alkylating agent, or low-dose total-body irradiation. The principle underlying reduced-intensity conditioning regimens is to provide tumor killing by choosing drugs with proven activities against the targeted malignancies while waiting for graft-versus-tumor effects to occur. Cytotoxic conditioning chemotherapy also serves to suppress the host-versus-graft reactions. The approach to nonmyeloablative conditioning employs an immunosuppressive regimen that is minimally myelosuppressive. Several immunosuppressive drugs are used after HCT for the dual purposes of enhancing engraftment and controlling graft-versus-host disease (GVHD) [3] . Thus, these conditioning regimens pre-HCT and immunosuppressive drugs post-HCT may influence the occurrence and severity of oral mucositis.
In this study, oral mucositis was evaluated in patients undergoing RIST and the findings were compared with those in conventional allogeneic HCT patients to facilitate effective and predictive measures of the possible risk of systemic bacteremia infection and intolerable pain caused by oral mucositis. 
Materials and methods

Patients
Assessment of oral mucositis
Severity of oral mucositis in patients undergoing HCT was evaluated everyday according to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 3.0 [9] . The criteria for oral mucositis were as follows: Assessments were performed as part of daily nursing by nurses under the instruction of dentists and dental hygienists, and the consistency of assessments was checked during the rounds of dentists and dental hygienists at least once per week. Assessment of use of morphine to control pain due to oral mucositis Use of morphine to control pain due to oral mucositis was evaluated for all patients. Differences in the frequency of patients used morphine among HCT types were analyzed.
Statistical analysis
Differences in the severity of mucositis and use of morphine among HCT types were analyzed by χ 2 test. When the data for χ 2 test analysis included a probability less than 5, Yates' continuity correction was applied. P values were calculated using the statistical software StatFlex (Artech, Osaka, Japan).
Results
Clinical course of oral mucositis in RIST and conventional HCT
The clinical courses of oral mucositis in patients undergoing conventional allogeneic HCT and RIST are shown in Fig. 1a, b . In conventional HCT, almost all patients suffered from mucosal damage. Severe mucositis (grades 3 and 4) was observed in 22.2% of patients treated using the conventional regimen, while the value in RIST patients was 4.7%. Ulcerative mucositis (>grade 2) was observed in about half of the patients, while the incidence of ulcerative mucositis (>grade 2) increased slowly and reached only 20% in the patients after RIST. There were no grade 4 lesions in RIST patients.
Clinical courses of oral ulcerative mucositis in RIST and conventional HCT
The clinical courses of oral ulcerative mucositis (>grade 2) in patients receiving RIST and conventional HCT are shown in Fig. 2 . Ulcerative mucositis (>grade 2) was detected most frequently 8 days after conventional HCT. However, ulcerative mucositis was detected most frequently in RIST patients on day 11, which was delayed compared with conventional HCT patients.
Maximal severity of mucositis in RIST and conventional HCT
The maximal severities of oral mucositis in patients undergoing conventional allogeneic and RIST are shown in Fig. 3 . A significant difference in maximal severity was observed between conventional HCT and RIST (P<0.05, χ 2 test), and the severity of oral mucositis was reduced in patients undergoing RIST compared with conventional allogeneic HCT.
Use of morphine to control pain due to oral mucositis
The frequencies of morphine use to control pain due to oral mucositis in patients undergoing conventional HCT and RIST are shown in Fig. 4 . Of the patients receiving conventional HCT, 55.6% required morphine to control pain due to oral mucositis. However, a significantly lower percentage of patients undergoing RIST (12.5%) required morphine to control pain due to oral mucositis.
Discussion
The results of this study can be summarized as follows. (1) Severity of oral mucositis was reduced in patients under- The severity of clinically evident mucosal damage generally increases and peaks between 6 and 12 days post-HCT with resolution of uncomplicated mucositis occurring over the subsequent 7 to 10 days [2, 8] , consistent with our findings in conventional HCT patients. On the other hand, there was a characteristic tendency toward a delay in the increase of mucosal damage in RIST patients compared with patients receiving conventional HCT. Furthermore, the frequency of ulcerative lesions was low compared with the conventional HCT patients throughout the HCT period as shown in Fig. 2 . In both conventional HCT and RIST, postgrafting immunosuppression mainly by methotrexate (MTX) is used for the dual purposes of enhancing engraftment and controlling GVHD [3] . We usually administer MTX on days 3, 7, and 10 after both HCT regimens. An intensive conditioning regimen for HCT resulted in severe mucositis about 10 days after conventional HCT and may have made the side effects of MTX unclear. However, in patients undergoing RIST, oral mucositis due to the conditioning regimen was mild and the delayed peak severity of oral mucositis was associated with MTX rather than the conditioning regimen.
Severe mucositis is associated with a risk of systemic infection related to bacteremia. Our previous studies showed that not only normal oral flora but also opportunistic bacteria appear on the oral mucosa [7] . It was also reported that the appearance of multidrug-resistant opportunistic bacteria may be involved in fatal sepsis [4] . The reduced-intensity conditioning regimen for HCT leads to a reduction in the degree of oral mucositis, which may explain the reduced risk of infection in cases treated in this way. Severe oral mucositis is also associated with intolerable pain, which is often controlled with by administration of morphine. Recent trends in cancer pain control recommend the appropriate use of narcotics to minimize pain. Our hospital also has this policy, and the use of narcotics in cancer treatment has increased during the examination period (2003) (2004) (2005) (2006) (2007) . Despite this trend, the use of morphine was significantly lower in RIST patients compared to those receiving conventional HCT. As RIST leads to a decrease in use of narcotics, the major side effects of morphine, such as ileus, could be avoided.
From the perspective of medical staff providing oral care during HCT, including nurses, dentists, and dental hygienists, oral care for oral mucositis should be given priority in conventional allogeneic HCT patients rather than RIST patients. On the other hand, it should be understood that there is a tendency for the peak of oral mucositis to be delayed in RIST patients and attention should be paid to the most severe period although it may be relatively mild compared with conventional HCT.
In conclusion, we compared oral mucositis in patients undergoing RIST to that in those receiving conventional allogeneic HCT. Severity of oral mucositis was reduced and the peak day of oral mucositis was delayed in RIST patients compared with that in conventional HCT patients.
